For the quarter ending 2026-03-31, SNWV made $9,619K in revenue. -$1,439K in net income. Net profit margin of -14.96%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 9,619 | 13,094 | 11,451 | 10,164 |
| Cost of revenues | 2,188 | 3,392 | 2,526 | 2,206 |
| Gross margin | 7,431 | 9,702 | 8,925 | 7,958 |
| General and administrative | 5,250 | 6,056 | 4,810 | 4,039 |
| Selling and marketing | 2,399 | 2,133 | 2,081 | 1,674 |
| Research and development | 660 | 606 | 345 | 194 |
| Depreciation and amortization | 246 | 292 | 222 | 174 |
| Total operating expenses | 8,555 | 9,087 | 7,458 | 6,081 |
| Operating (loss) income | -1,124 | 615 | 1,467 | 1,877 |
| Interest expense-Nonrelated Party | - | 1,429* | 1,722 | 1,874 |
| Interest expense-Related Party | - | 0* | 0 | 0 |
| (gain) loss on extinguishment of debt | - | 239* | -477 | 0 |
| Interest expense | 546 | - | - | - |
| Change in fair value of derivative liabilities | 0 | -5,921 | -6,097 | -990 |
| Gain on impairment of assets | - | -392* | 196 | - |
| Other expense | 60 | 0 | 14 | 27 |
| Other income | 291 | 457 | 5,170 | 89 |
| Total other expense, net | -315 | 5,580 | 8,858 | -822 |
| Net income (loss) before income taxes | - | 6,131* | - | - |
| Income tax expense | - | 22* | - | - |
| Net loss | -1,439 | 6,109 | 10,325 | 1,055 |
| Foreign currency translation adjustments | 0 | 0 | 0 | 0 |
| Total comprehensive loss | -1,439 | 6,109 | 10,325 | 1,055 |
| Basic EPS | -0.17 | 0.713 | 1.2 | 0.12 |
| Diluted EPS | -0.17 | 0.645 | 0.46 | 0.01 |
| Basic Average Shares | 8,591,098 | 8,573,517 | 8,571,111 | 8,561,737 |
| Diluted Average Shares | 8,591,098 | 9,473,851 | 9,140,668 | 9,167,846 |
SANUWAVE Health, Inc. (SNWV)
SANUWAVE Health, Inc. (SNWV)